Many patients at Seattle Cancer Care Alliance (SCCA) receive promising therapies by taking part in clinical trials. These research studies are done by physician-scientists from SCCA, Fred Hutchinson Cancer Research Center and UW Medicine. They test new treatments or new ways to use current treatments.
Every advance in cancer treatment in recent years has come out of clinical trials. We offer more active clinical trials than anywhere else, which means more treatment options for patients like you.
For some people, taking part in a clinical study may be the best treatment choice. Access to clinical studies by researchers at SCCA and our founding organizations Fred Hutch and UW Medicine is one reason many patients come to SCCA.
Our scientists and doctors are conducting novel pancreatic cancer studies, and we're part of the Pancreatic Cancer Action Network Precision Promise Clinical Trials Consortium, designed to quickly and dramatically improve outcomes for the disease.
Pancreatic cancer is difficult to treat in part because the tumor builds a biological barrier around itself that keeps chemotherapy out. SCCA’s Sunil Hingorani, MD, and his research team found a way to dissolve this barrier with an enzyme known as PEGPH20. Their research led to a series of clinical trials combining PEGPH20 with chemotherapy with promising results.
Your SCCA team will talk with you about available studies that are appropriate for you and could give you access to promising new options.